Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection

Detalles Bibliográficos
Autores principales: Liu, Fuchen, Feng, Xiaochen, Du, Jin, Ruan, Minghao, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880698/
https://www.ncbi.nlm.nih.gov/pubmed/36566347
http://dx.doi.org/10.1002/cac2.12398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880698/
https://www.ncbi.nlm.nih.gov/pubmed/36566347
http://dx.doi.org/10.1002/cac2.12398

Ejemplares similares